Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.3599
-0.0011 (-0.30%)
At close: Nov 3, 2026, 4:00 PM EST
0.3554
-0.0045 (-1.25%)
After-hours: Nov 3, 2026, 7:30 PM EST
Evogene Employees
Evogene had 52 employees as of December 31, 2025. The number of employees decreased by 65 or 55.56% compared to the previous year.
Employees
52
Change (1Y)
-65
Growth (1Y)
-55.56%
Revenue / Employee
$31,865
Profits / Employee
-$174,481
Market Cap
5.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 52 | -65 | -55.56% | 52 | 0 |
| Dec 31, 2024 | 117 | -25 | -17.61% | 117 | 0 |
| Dec 31, 2023 | 142 | 5 | 3.65% | 142 | 0 |
| Dec 31, 2022 | 137 | -4 | -2.84% | 137 | 0 |
| Dec 31, 2021 | 141 | 10 | 7.63% | 141 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| FibroBiologics | 15 |
| Processa Pharmaceuticals | 12 |
| Aprea Therapeutics | 8 |
| Alzamend Neuro | 6 |
| Enveric Biosciences | 6 |
| XTL Biopharmaceuticals | 5 |
| Acurx Pharmaceuticals | 4 |
EVGN News
- 6 days ago - Evogene Targets Acute GVHD With AI-Driven Drug Discovery Program - Nasdaq
- 6 days ago - Evogene Ltd. Announces Acute Graft-Versus-Host Disease (aGVHD) as Target Indication for Drug Discovery Program on October 28, 2026 - Nasdaq
- 6 days ago - Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program - PRNewsWire
- 8 days ago - Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain - PRNewsWire
- 14 days ago - Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL - PRNewsWire
- 4 weeks ago - Evogene announces cooperation agreement with Pure Capital Group - TheFly
- 4 weeks ago - Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors - PRNewsWire
- 4 weeks ago - Evogene Gets 180-day Nasdaq Extension To Regain Compliance - Nasdaq